1.Mølbak, K et al. (2015) Excess mortality among the elderly in European countries, December 2014 to February 2015. Eurosurveillance 20(11), pii=21065.
3.Hawkes, N (2016) Sharp spike in deaths in England and Wales needs investigating, says public health expert. British Medical Journal 352, i981. Available at http://www.bmj.com/content/352/bmj.i981.
4.Serfling, RE, Sherman, IL and Houseworth, WJ (1967) Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957–58, 1960 and 1963. American Journal of Epidemiology 86(2), 433–441.
5.Nielsen, et al. (2013) Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011. Epidemiology and Infection 141, 1996–2010.
8.Brown, G, Fearn, V and Wells, C (2010) Exploratory analysis of seasonal mortality in England and Wales, 1998 to 2007. Health Statistics Quarterly 48(Winter), 58–80. doi: 10.1057/hsq.2010.21.
9.Green, HK et al. (2013) Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic. PLoS ONE 8(12), e79360.
10.Leon-Gomez, I et al. (2015) Excess mortality associated with influenza in Spain in winter 2012. Gaceta Sanitaria 29(4), 258–265.
11.Matias, G et al. (2014) Estimates of mortality attributable to influenza and RSV in the United States during 1997–2009 by influenza type or subtype, age, cause of death, and risk status. Influenza and Other Respiratory Viruses 8(5), 507–515.
12.Wu, P et al. (2014) Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong. Influenza and Other Respiratory Viruses 8(1), 1–7.
13.van Asten, L et al. (2012) Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. Journal of Infectious Diseases 206(5), 628–639.
14.Nielsen, J et al. (2011) Excess mortality related to seasonal influenza and extreme temperatures in Denmark, 1994–2010. BMC Infectious Diseases 11, 350.
15.Espenhain, L, on behalf of the EuroMOMO partners (2014) FluMOMO: a coordinated European approach to estimate influenza-attributable excess mortality in almost real-time. Vienna, Austria: Joint Annual European Influenza Surveillance Meeting, ECDC/WHO.
16.Goldstein, E et al. (2011) Predicting the epidemic sizes of influenza A/H1N1, A(H3N2), and B: a statistical method. PLoS Medicine 8(7), e1001051.
18.Nielsen, J, Krause, TG and Mølbak, K (2018) Influenza associated mortality determined from all-cause mortality, Denmark 2010/11-2016/17: The FluMOMO model. Influenza Other Respir Viruses. 2018 Apr 16. doi: 10.1111/irv.12564.
19.Goddard, NL et al. (2000) Influenza surveillance in England and Wales: October 1999 to May 2000. Communicable Disease and Public Health 3, 261–266.
20.Pebody, R et al. (2015) Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveillance 20(36).
21.Pebody, R et al. (2017) End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. Euro Surveillance 22(44). doi: 10.2807/1560-7917.ES.2017.22.44.17-00306.
22.Belongia, EA et al. (2016) Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. The Lancet Infectious Diseases 16(8), 942–951. doi: 10.1016/S1473-3099(16)00129-8.
23.Hardelid, P et al. (2012) Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008–2010: results from a cohort study in general practice. Vaccine 30(7), 1371–1378. doi: 10.1016/j.vaccine.2011.12.038.
24.Baguelin, M et al. (2012) Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine 30(23), 3459–3462. doi: 10.1016/j.vaccine.2012.03.019.
25.Wilkinson, K et al. (2017) Efficacy and safety of high-dose influenza vaccine in elderly adults: a systematic review and meta-analysis. Vaccine 35(21), 2775–2780. doi: 10.1016/j.vaccine.2017.03.092.
26.Domnich, A et al. (2017) Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis. Vaccine 35(4), 513–520. doi: 10.1016/j.vaccine.2016.12.011.
27.Pebody, RG et al. (2010) Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveillance 15(20), pii: 19571.
28.Miller, E et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375(9720), 1100–1108. doi: 10.1016/S0140-6736(09)62126-7.
29.Dawood, FS et al. (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. The Lancet Infectious Diseases 12(9), 687–695. doi: 10.1016/S1473-3099(12)70121-4.
30.Baguelin, M et al. (2013) Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Medicine 10(10), e1001527. doi: 10.1371/journal.pmed.1001527.
31.Gordon, D et al. (2017) The GP's role in promoting winter wellness. British Journal General Practice 67(655), 53. doi: 10.3399/bjgp17X688909.
32.Hardelid, P, Pebody, R and Andrews, N (2013) Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999–2010. Influenza and Other Respiratory Viruses 7(1), 35–45. doi: 10.1111/j.1750-2659.2012.00345.x.
33.Simonsen, et al. (2013) Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Medicine 10(11), e1001558. doi: 10.1371/journal.pmed.1001558.